证券之星消息，截至2026年1月21日收盘，迈得医疗(688310)报收于16.51元，上涨1.54%，换手率 1.49%，成交量2.47万手，成交额4073.95万元。 1月21日的资金流向数据方面，主力资金净流出363.54万元，占总成交额8.92%，游资资金净流入207.68 万元，占总成交额5.1%，散户资金净流入155.86万元，占总成交额3.83%。 近5日资金流向一览见下表： 迈得医疗2025年三季报显示，前三季度公司主营收入2.25亿元，同比上升2.31%；归母净利润883.67万 元，同比上升15.82%；扣非净利润-127.85万元，同比下降526.58%；其中2025年第三季度，公司单季度 主营收入8364.3万元，同比上升54.38%；单季度归母净利润279.16万元，同比上升224.07%；单季度扣 非净利润123.64万元，同比上升118.23%；负债率29.86%，投资收益16.76万元，财务费用-52.36万元， 毛利率40.19%。迈得医疗（688310）主营业务：医用耗材智能装备的研发、生产、销售和服务,有效整 合医疗器械产品工艺、自动化、软件等方面的技术,形成独特的产品与 ...

Core Viewpoint - As of December 26, 2025, Maide Medical (688310) closed at 15.47 yuan, down 1.59%, with a turnover rate of 1.46% and a trading volume of 24,300 lots, amounting to 38.0012 million yuan in transaction value [1] Group 1: Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, an increase of 2.31% year-on-year [2] - The net profit attributable to shareholders was 8.8367 million yuan, up 15.82% year-on-year [2] - The non-recurring net profit was -1.2785 million yuan, a significant decrease of 526.58% year-on-year [2] - In Q3 2025, the company achieved a single-quarter main revenue of 83.643 million yuan, a year-on-year increase of 54.38% [2] - The single-quarter net profit attributable to shareholders was 2.7916 million yuan, up 224.07% year-on-year [2] - The single-quarter non-recurring net profit was 1.2364 million yuan, an increase of 118.23% year-on-year [2] - The company's debt ratio stood at 29.86%, with investment income of 167,600 yuan and financial expenses of -523,600 yuan, while the gross profit margin was 40.19% [2] Group 2: Business Overview - Maide Medical specializes in the research, production, sales, and service of medical consumables and intelligent equipment, effectively integrating technology in medical device processes, automation, and software [2]